Skip to content
Research Article Open access CC BY 4.0

Interleukin-6 and Ferritin as Prognosticators in SARS-CoV-2 Patients from Kashmir, North India

Iqra Farooq, Rafiqa Eachkoti, Masood Tanvir, Saleem Hussain, Sanah Farooq, Ifrah Jan, Sadaf Saleem, Sabhiya Majid

Asian Journal of Biochemistry, Genetics and Molecular Biology · pp. 37–50 · Published 9 Feb 2023

10.9734/ajbgmb/2023/v13i1287

Abstract

Background: Identifying early predictive biomarkers of disease severity and disease outcome is fundamental for the practical management of Covid -19 patients. Although prognostic value of several Pro- and inflammatory markers have been determined in different population studies, however, it remained to be determined in SARS-CoV-2 patients from Kashmir. Aim: To evaluate the predictive value of ferritin and IL-6 levels in RT- PCR confirmed SARS-CoV-2 patients from Kashmir. Study Design: A Cohort Study. Place and Duration of Study: The study was done at Government Medical College, Srinagar Kashmir, North India between October 2020 to November 2021. Method: Here, we estimated ferritin and IL-6 levels respectively by chemiluminescent method on fully automated immune analyzer and by ELISA in a cohort of 100 RT-PCR confirmed SARS-CoV-2 patients, which were followed twice (14th and 28th day) for a period of  one month. Results: Based on estimated ferritin levels, the cohort was categorized into Mild = <500 ng/ml, Moderate = ≥500-<1500, and High = ≥1500ng/ml. Also patients were grouped as Mild = 0-<10pg/ml, Moderate = ≥10-<80pg/ml and High =≥80pg/ml based on Interleukin IL-6 levels. Correlation analysis of SARS-CoV-2 patients of varying ferritin levels with disease severity revealed a percent increase in the number of patients of stage 3 severity as ferritin levels increased from mild, to moderate and high levels. Similarly, a percent increase in the number of SARS-CoV-2 patients of increased severity was found as IL-6 levels increased from mild to moderate and high levels. Further, the ROC analysis of ferritin and IL-6 levels with disease outcome suggested both ferritin and IL-6 as early predictive markers of poor disease outcome. However, IL-6, with AUC =0.70 and sensitivity of 70% and specificity of 62%, is a better early predictive marker of poor disease outcome than ferritin with AUC=0.66 at sensitivity of 60% and specificity of 68% in SARS-CoV-2 patients from Kashmir. Further ROC analysis of patients with very high ferritin levels (>1500ng/ml) alone suggests it as an early predictive marker of patients with hyperinflammatory phenotype. Conclusion: Estimation of ferritin and IL-6 levels as simple complementary early prognostic markers that are helpful in clinical decision-making and selecting appropriate treatment options in SARS-CoV-2 patients from Kashmir, North India.

Ferritin IL-6 cytokine storm SARS-CoV-2 pathophysiology RT-PCR

References (12)

  1. 1 Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding [DOI]
  2. 2 Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome [DOI]
  3. 3 Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study [DOI]
  4. 4 The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019 [DOI]
  5. 5 The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome [DOI]
  6. 6 COVID–19-associated coagulopathy: An exploration of mechanisms [DOI]
  7. 7 Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis [DOI]
  8. 8 Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2‐mediated mechanism† [DOI]
  9. 9 Depriving Iron Supply to the Virus Represents a Promising Adjuvant Therapeutic Against Viral Survival [DOI]
  10. 10 Iron–sulfur clusters in nucleic acid metabolism: Varying roles of ancient cofactors [DOI]
  11. 11 Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection [DOI]
  12. 12 Comorbidities, Infections, and Mortalities of COVID-19 in Bangladesh During May-June 2021 [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

36

Page views

0

PDF downloads

4

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.